Deletion of microRNA miR-223 increases Langerhans cell cross-presentation

Qing-Sheng Mi1, Ying-Ping Xu, He Wang

  • 1Henry Ford Immunology Program, Henry Ford Health System, Detroit, MI, United States. qmi1@hfhs.org

Insights

MicroRNA miR-223 negatively regulates Langerhans cell (LC) cross-presentation. While its absence doesn't affect LC development or homeostasis, it enhances antigen-specific CD8(+) T cell proliferation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Dermatology

Background:

  • Langerhans cells (LCs) are crucial skin immune cells.
  • MicroRNAs (miRNAs) regulate cellular functions, but individual roles in LCs are unclear.
  • miR-223 is expressed in myeloid cells and highly in epidermal LCs.

Purpose of the Study:

  • To investigate the role of miR-223 in regulating the development and function of epidermal LCs.
  • To determine if miR-223 impacts LC homeostasis, maturation, migration, and antigen presentation.

Main Methods:

  • Utilized miR-223 knockout (KO) mice and wild-type (WT) littermates.
  • Assessed LC number, maturation, migration, and phagocytic capacity.
  • Evaluated LC-mediated antigen-specific CD8(+) and CD4(+) T cell proliferation in vitro and in vivo.

Main Results:

  • LC number, maturation, migration, and phagocytosis were similar between miR-223 KO and WT mice.
  • Lack of miR-223 significantly enhanced LC cross-presentation of antigens to CD8(+) T cells.
  • miR-223 deficiency did not affect LC stimulation of CD4(+) T cells.

Conclusions:

  • miR-223 negatively regulates the cross-presentation function of Langerhans cells.
  • miR-223 is not essential for the basic homeostasis and development of LCs.
  • This finding highlights a specific regulatory role for miR-223 in adaptive immunity mediated by LCs.